Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease

Summary

The goal of this clinical trial is to determine if doxofylline and procaterol are effective in treating patients with stable chronic obstructive pulmonary disease (COPD). It will also assess the safety of both drugs. The main questions it aims to answer are: * Does doxofylline demonstrate a comparable bronchodilator effect to procaterol in COPD participants? * What medical problems do participants experience when taking doxofylline and procaterol?"

Timeline

Start

2024-03-01

Primary completion

2024-10-31

Completion

2024-11-15

Drugs

Indications